Back to search
FDAFDA · Food and drugs·Recall number D-0730-2016

Thyrogen (thyrotropin alfa for injection), 0.9 mg/mL after reconstitution, For intramuscular injection only, Rx Only, Two vials per Carton, Carton contains 2 vials of Thyrogen, Dilute with Sterile Water for Injection, Storage: store at 2-8 C, Manufactured by: Genzyme Corporation, Northborough, MA 01532 USA, Marketing Authorization holder: Sanofi-Aventis, NDC 58468-0030-2.

Published March 9, 2016 · Recall initiated: February 16, 2016

Summary

FDA records drug Class II recall D-0730-2016, published March 9, 2016 and initiated February 16, 2016. Recalling firm: Genzyme Corporation; Status: Terminated; Reported quantity: 4669 Cartons; Lot: Lot #s: E4029Y03, E4029Y04, E4029Y06, E4029Y07, Exp 12/2017. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Presence of Particulate Matter: Glass particles found in the product after reconstitution.

What to do

Voluntary: Firm initiated · Telephone

Get an email if THYROGEN has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
THYROGEN
Manufacturer
Genzyme Corporation
Distributor
Nationwide, Puerto Rico and Malaysia, Taiwan, Brazil, and Israel.
Lot
Lot #s: E4029Y03, E4029Y04, E4029Y06, E4029Y07, Exp 12/2017
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Thyrogen (thyrotropin alfa for injection), 0.9 mg/mL after reconstitution, For intramuscular injection only, Rx Only, Two vials per Carton, Carton contains 2 vials of Thyrogen, Dilute with Sterile Water for Injection, Storage: store at 2-8 C, Manufactured by: Genzyme Corporation, Northborough, MA 01532 USA, Marketing Authorization holder: Sanofi-Aventis, NDC 58468-0030-2. recalled?

Yes. FDA published recall D-0730-2016 on March 9, 2016. Reported hazard: Presence of Particulate Matter: Glass particles found in the product after reconstitution.

What should I do if I have this product?

Voluntary: Firm initiated · Telephone

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: THYROGEN.